MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-BR-26-0023915
Shiracal Pharmaceutical Private Limited
Shiracal Pharmaceutical Private Limited - pharma in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.15 Lakh
▼ 18% YoY
Net loss · FY 2024
₹71,811
Net margin -13.9%
EBITDA · FY 2024
-₹63,184
EBITDA margin -12.3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Shiracal Pharmaceutical Private Limited
Data last updated:
Shiracal Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 May 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51900KA2018PTC113174. Its GSTIN is 10ABACS3203M1ZT (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Keshri Kumar and Shashi Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Santosh Kr Yadav 13 Prema Devi Nivas 10th C Cross Anepalya Gajendra Nagar, Bangalore, Karnataka, India – 560030.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.15 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹71,811 (net margin -13.9%) and EBITDA of -₹63,184 (EBITDA margin -12.3%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 98% over five years.
Shiracal Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0023915).
Company details
CIN U51900KA2018PTC113174
Registration Number 113174
Incorporation Date 16 May 2018
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0023915
Recognitions & Rankings of Shiracal Pharmaceutical
Contact details
Shiracal Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Santosh Kr Yadav 13 Prema Devi Nivas 10th C Cross Anepalya Gajendra Nagar, Bangalore, Karnataka, India – 560030
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Shiracal Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Shiracal Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Shiracal Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Shiracal Pharmaceutical Private Limited, buy the company report.
Financials of Shiracal Pharmaceutical Private Limited
FY 2025 filings availableShiracal Pharmaceutical Private Limited reported revenue of ₹5.15 Lakh (down 18% YoY) for FY 2024.
Revenue · FY 2024
₹5.15 Lakh ▼ 18%
Net loss · FY 2024
₹71,811 margin -13.9%
EBITDA · FY 2024
-₹63,184 margin -12.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 6%
5 years · compounded
▲ 98%
EBITDA CAGR growth
1 year
▼ 226%
3 years · compounded
▼ 7%
5 years · compounded
▲ 4%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 98%. EBITDA fell 226% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹63,184 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹71,811 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -12.3% | ||||
| Net Profit Margin | -13.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shiracal Pharmaceutical Private Limited, buy the company report.
Board of directors of Shiracal Pharmaceutical Private Limited
Shiracal Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Keshri Kumar | Director | 16 May 2018 | 8 Years 5 Months | Current |
| Shashi Kumar | Director | 16 May 2018 | 8 Years 5 Months | Current |
Peer comparison
Shiracal Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Texcyle Enterprises Private Limited | ₹5.2 Lakh (FY 2025) | Jaipur, Rajasthan, India | ||||
| Vajra Biotech Private Limited | ₹5.2 Lakh (FY 2025) | 104.0% | Kadur, Karnataka, India | |||
| Tiraz Pharmaceutical Private Limited | ₹5.18 Lakh (FY 2025) | 11.0% | Pune, Maharashtra, India | |||
| Continental Computers Private Limited | ₹5.17 Lakh (FY 2024) | -25.0% | Kolkata, West Bengal, India | |||
| Zedsons Pharma Private Limited | ₹5.16 Lakh (FY 2024) | 4.0% | Kolkata, West Bengal, India | |||
| Shiracal Pharmaceutical Private Limitedthis company | ₹5.15 Lakh (FY 2024) | -₹71,811 | -13.9% | -18.0% | Bangalore, Karnataka, India | |
| Sunishchit India Private Limited | ₹5.15 Lakh (FY 2025) | 80.0% | Delhi, India | |||
| Nandica Retails Private Limited | ₹5.15 Lakh (FY 2025) | -58.0% | Agra, Uttar Pradesh, India | |||
| Zenvact Lifesciences Private Limited | ₹5.13 Lakh (FY 2025) | -68.0% | Panchkula, Haryana, India | |||
| Immanence Pharmaceuticals Private Limited | ₹5.13 Lakh (FY 2024) | -26.0% | Badlapur, Maharashtra, India | |||
| Oms Innovative Private Limited | ₹5.13 Lakh (FY 2025) | -78.0% | New Delhi, Delhi, India |
To see the full peer comparison of Shiracal Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shiracal Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shiracal Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shiracal Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10ABACS3203M1ZT | Bihar | Active | 04 Dec 2018 |
To see the full GST registrations and return filing status of Shiracal Pharmaceutical Private Limited, buy the company report.
Recent activity
Shiracal Pharmaceutical Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Rajeev Keshri Kumar was appointed as Director on 16 May 2018.
AGM
Shiracal Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Shiracal Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Appointed
Rajeev Keshri Kumar was appointed as Director.
Appointed
Shashi Kumar was appointed as Director.
Incorporation
16 May 2018
Shiracal Pharmaceutical Private Limited was registered on 16 May 2018 with Roc Bangalore & aged 8 years 5 months as per MCA records.
Frequently asked questions
Shiracal Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 May 2018 (8+ years old) and is registered under CIN U51900KA2018PTC113174.
Shiracal Pharmaceutical has 2 current directors:
- Rajeev Keshri Kumar - Director
- Shashi Kumar - Director
The latest financial statements of Shiracal Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Shiracal Pharmaceutical is 10ABACS3203M1ZT, registered in Bihar.
The CIN (Corporate Identification Number) of Shiracal Pharmaceutical is U51900KA2018PTC113174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shiracal Pharmaceutical was incorporated on 16 May 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Shiracal Pharmaceutical by revenue are Texcyle Enterprises Private Limited, Vajra Biotech Private Limited, Tiraz Pharmaceutical Private Limited, Continental Computers Private Limited, Zedsons Pharma Private Limited and 5 more, all in the same principal business activity (wholesale and retail trade and repair of motor vehicles and motorcycles).
Rajeev Keshri Kumar was appointed as Director on 16 May 2018. Shashi Kumar was appointed as Director on 16 May 2018.
Yes, Shiracal Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0023915).
The registered office of Shiracal Pharmaceutical is at CO Santosh Kr Yadav 13 Prema Devi Nivas 10th C Cross Anepalya Gajendra Nagar, Bangalore, Karnataka, India – 560030.
Shiracal Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages